Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis.

Published

Journal Article

Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregnancy and the postpartum period. These drugs are capable of crossing the placenta and being transferred to the newborn during lactation. This report reviews the available information regarding the effects of SSRIs on the fetus and newborn; including long-term neurodevelopmental outcomes.

Full Text

Cited Authors

  • Lattimore, KA; Donn, SM; Kaciroti, N; Kemper, AR; Neal, CR; Vazquez, DM

Published Date

  • September 2005

Published In

Volume / Issue

  • 25 / 9

Start / End Page

  • 595 - 604

PubMed ID

  • 16015372

Pubmed Central ID

  • 16015372

Electronic International Standard Serial Number (EISSN)

  • 1476-5543

International Standard Serial Number (ISSN)

  • 0743-8346

Digital Object Identifier (DOI)

  • 10.1038/sj.jp.7211352

Language

  • eng